Bradley Hardiman
InvestorInvestor at Spex Capital
Cambridge, United Kingdom
Writes $100K – $5M checks · typically $1.5M
About
Bradley Hardiman is a consulting executive with experience in life science venture capital, business development, and technology transfer. He has worked on equity investments and licensing arrangements, combining a scientific background with commercial expertise. Hardiman currently provides freelance consulting services and participates in ecosystem development through advisory roles and entrepreneurial initiatives.
Experience
- FreelanceFreelance Consultingcurrent2024 — present
- InnovationRCAVisiting Business Fellowcurrent2012 — presentLondon, United Kingdom
- Astellas EuropeSenior Director, Ventures - Business Development2023 — 2024Cambridge, England, United Kingdom
- Astellas EuropeSenior Director, Scouting & Transaction - Business Development2023 — 2024Cambridge, England, United Kingdom
- Astellas EuropeHead of Europe, Search & Evaluation - Business Development2022 — 2023Cambridge, England, United Kingdom
- Astellas EuropeSenior Director, Astellas Innovation Management - Scouting2021 — 2022Cambridge, England, United Kingdom
- Spex CapitalInvestor2021 — 2024London, England, United Kingdom
- Adrenaline Capital PartnersPartner2019 — 2021London, United Kingdom
- Future Care CapitalManaging Partner, Investment Fund2017 — 2019London, United Kingdom
- HealtheraBoard Observer2018 — 2019Cambridge, United Kingdom
- Cambridge EnterpriseInvestment Director (Investment Manager 2010 - 2016)2010 — 2017Cambridge, United Kingdom
- Carrick TherapeuticsBoard Observer2015 — 2017
- QuetheraDirector2015 — 2017Cambridge, United Kingdom
- Storm Therapeutics (formerly Iceni Therapeutics)Board Observer2015 — 2017
- Fluidic AnalyticsDirector2015 — 2017Cambridge, United Kingdom
- DefinigenDirector2012 — 2017Cambridge, United Kingdom
- Cambridge Enterprise Venture PartnersCo-ordinator2010 — 2017Cambridge, United Kingdom
- Inotec AMDBoard Observer (Director until April 2016)2011 — 2017
- CambfixDirector2010 — 2013
- Input DynamicsDirector2011 — 2012
Education
- CFAInvestment Management Certificate (Part 1), Finance and Financial Management Services2012
- Bayes Business SchoolMBA, Executive Masters of Business Administration2004 — 2006
- University of CambridgeMSc (Res), Molecular Biochemistry1999 — 2001
- Brunel University of LondonBSc, Medical Biochemistry1993 — 1997
Skills & more
Investing4Venture Capital7Start-up Ventures5Business Development1Corporate Venture CapitalPharmaceutical ResearchLife Sciences2Startup DevelopmentBoard of DirectorsStartups2Panel ModeratorFinancial Analysis
+3 more
Business AnalysisAccountingAnalytical Skills- BVCA Investor Relations & Fundraising — UK Private Capital
From Bradley's professional profile.
Colleagues at Spex Capital
Agota Nika
Senior Advisor at Spex Capital
Alok Prasad
Investor at Spex Capital
Ana González Plaza
Analyst at Spex Capital
Arjun Agarwal
Senior Advisor at Spex Capital
Avi Lasarow
Senior Advisor at Spex Capital
Brent Stackhouse
General Partner / Investment Committee Member at Spex Capital
Charlotte McIntyre
Investor at Spex Capital
Claudio D'Angelo
Managing Director at Spex Capital
Network5
Alok Prasad
Investor at Spex Capital
Charlotte McIntyre
Investor at Spex Capital
Eugene Ong
Investor at Spex Capital
Filippo Falaschi
General Partner / Investment Committee Member at Spex Capital
Francis Pollen
Investor at Spex Capital
Investors connected to Bradley in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Bradley Hardiman work?
- Bradley Hardiman is Investor at Spex Capital.
- What check size does Bradley Hardiman write?
- Bradley Hardiman typically writes checks of $100K – $5M.
Same school
Also attended Bayes Business School51
Raoul Oscar FianoInvestor at DN CapitalLavinia FerriAssociate at P101 VenturesMiguel BagulhoDirector, Retail at Bright Pixel CapitalKatie ConnAccess Fund at Salica InvestmentsKit Blakiston-HoustonPrincipal at Fuel VenturesAnnie VeldmanSenior Associate at Catalyst Investors
+ 45 more
Also attended University of Cambridge851
Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)
.png)
+ 845 more
Also attended Brunel University of London27
Paul BazinInvestor at DaphniSimon MurdochGeneral Partner, PhD at Episode1Hamdullah MohibCEO, Marlan Space at Cortado VenturesTay SalimullahVenture Partner at 4BIO CapitalSurjit KoonerManaging Director, Regional at Future Planet CapitalAli QaiserMENA at Salica Investments
+ 21 more
Shared employers
Also worked at InnovationRCA1
Also worked at Healthera1
Also worked at Carrick Therapeutics6
Robert TansleyPartner at Cambridge Innovation CapitalAlan BargeVenture Partner at Delin VenturesCaroline GaynorPartner at Lightstone VenturesChristine MartinHead of Ventures at University of Cambridge EnterpriseJonathan HeppleManaging Partner at Rosetta Capital Ltd.Jason LettmannPartner at Morgenthaler
